Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Major bleeding in hemodialysis patients.

Holden RM, Harman GJ, Wang M, Holland D, Day AG.

Clin J Am Soc Nephrol. 2008 Jan;3(1):105-10. Epub 2007 Nov 14.

2.

Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates.

Elliott MJ, Zimmerman D, Holden RM.

Am J Kidney Dis. 2007 Sep;50(3):433-40. Review.

PMID:
17720522
3.

Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

Arjomand H, Cohen M, Ezekowitz MD.

J Invasive Cardiol. 2004 May;16(5):271-8. Review.

PMID:
15152137
4.

Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.

Warkentin AE, Donadini MP, Spencer FA, Lim W, Crowther M.

J Thromb Haemost. 2012 Apr;10(4):512-20. doi: 10.1111/j.1538-7836.2012.04635.x. Review.

5.

Antiplatelet therapy in anticoagulated patients requiring coronary intervention.

Arab D, Lewis B, Cho L, Steen L, Joyal D, Leya F.

J Invasive Cardiol. 2005 Oct;17(10):549-54. Review.

PMID:
16204751
6.

Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

Hermosillo AJ, Spinler SA.

Ann Pharmacother. 2008 Jun;42(6):790-805. doi: 10.1345/aph.1K591. Epub 2008 May 13. Review. Erratum in: Ann Pharmacother. 2008 Oct;42(10):1521.

PMID:
18477734
7.

Known knowns and known unknowns: risks associated with combination antithrombotic therapy.

Johnson S.

Thromb Res. 2008;123 Suppl 1:S7-11. doi: 10.1016/j.thromres.2008.08.011. Epub 2008 Oct 1. Review.

PMID:
18829070
8.

Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?

Usman MH, Notaro LA, Nagarakanti R, Brahin E, Dessain S, Gracely E, Ezekowitz MD.

Am J Cardiol. 2009 Apr 15;103(8):1107-12. doi: 10.1016/j.amjcard.2009.01.003. Epub 2009 Mar 4. Review.

PMID:
19361598
9.

Are major bleeding events from falls more likely in patients on warfarin?

Garvin R, Howard E.

J Fam Pract. 2006 Feb;55(2):159-60; discussion 159. Review.

PMID:
16451785
10.

Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.

Andersen LV, Vestergaard P, Deichgraeber P, Lindholt JS, Mortensen LS, Frost L.

Heart. 2008 Dec;94(12):1607-13. doi: 10.1136/hrt.2007.135657. Epub 2008 Jan 20. Review.

PMID:
18208828
11.

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

Landefeld CS, Beyth RJ.

Am J Med. 1993 Sep;95(3):315-28. Review.

PMID:
8368229
12.

Does warfarin safely prevent clotting of hemodialysis catheters? a review of efficacy and safety.

Willms L, Vercaigne LM.

Semin Dial. 2008 Jan-Feb;21(1):71-7. doi: 10.1111/j.1525-139X.2007.00381.x. Review.

PMID:
18251961
13.

Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.

Garwood CL, Corbett TL.

Ann Pharmacother. 2008 Apr;42(4):523-32. doi: 10.1345/aph.1K498. Epub 2008 Mar 11. Review.

PMID:
18334606
14.

A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery.

Lewis KG, Dufresne RG Jr.

Dermatol Surg. 2008 Feb;34(2):160-4; discussion 164-5. Epub 2007 Dec 17. Review.

PMID:
18093204
15.

Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?

Laine L.

Aliment Pharmacol Ther. 2006 Sep 15;24(6):897-908. Review.

16.

Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer's perspective.

Heeg B, Damen J, Van Hout B.

Pharmacoeconomics. 2007;25(12):1063-82. Review.

PMID:
18047390
17.

Antiplatelet agents and arterial thrombosis.

Billett HH.

Cardiol Clin. 2008 May;26(2):189-201, vi. doi: 10.1016/j.ccl.2007.12.007. Review.

PMID:
18406994
18.

Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

Semin Thromb Hemost. 2008 Feb;34(1):58-73. doi: 10.1055/s-2008-1066025. Review.

PMID:
18393143
19.

Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why?

Douketis JD.

Thromb Res. 2011 Jun;127(6):513-7. doi: 10.1016/j.thromres.2011.02.010. Epub 2011 Mar 31. Review.

PMID:
21458032
20.

Bleeding risks of antithrombotic therapy.

Fitzmaurice DA, Blann AD, Lip GY.

BMJ. 2002 Oct 12;325(7368):828-31. Review. No abstract available.

Supplemental Content

Support Center